GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » 3-Year Dividend Growth Rate

Abingdon Health (Abingdon Health) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health 3-Year Dividend Growth Rate?

Abingdon Health's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The historical rank and industry rank for Abingdon Health's 3-Year Dividend Growth Rate or its related term are showing as below:

ABDXF's 3-Year Dividend Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 10.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Abingdon Health's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Abingdon Health's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Abingdon Health's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, Abingdon Health's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Abingdon Health's 3-Year Dividend Growth Rate falls into.



Abingdon Health 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Abingdon Health  (OTCPK:ABDXF) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Abingdon Health's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.005
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health 3-Year Dividend Growth Rate Related Terms>


Abingdon Health (Abingdon Health) Business Description

Traded in Other Exchanges
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire 02-16-2021